Results 81 to 90 of about 1,134,429 (320)
Masked uncontrolled hypertension [PDF]
Journal of Hypertension, 2019 Juan M, Mejia-Vilet +7 more
+8 more sources
Рациональная фармакотерапия в кардиологии, 2017 Background. The seasonal variability of blood pressure (BP) and cardiovascular morbidity and mortality motivates researchers to search for the new approaches of the antihypertensive treatment (AHT) efficacy assessment, including the analysis of ...
M. I. Smirnova +8 more
doaj +1 more source
Changes in the 2017 Pediatric Hypertension Clinical Guidelines. [PDF]
, 2018 The clinical practice guidelines on diagnosis and management of high blood pressure in children and adolescents have been periodically modified and updated since the original publication in 1977.1 Since the last pediatric blood pressure guideline was ...
Falkner, Bonita
core +1 more source
Identifying masked uncontrolled hypertension in the community pharmacy setting [PDF]
, 2015 © 2015 Wolters Kluwer Health, Inc. Masked uncontrolled hypertension (MUCH) is associated with an increased cardiovascular risk. This condition is frequent in the community pharmacy (i.e., CP-MUCH), but there is no evidence on the factors associated with ...
Benrimoj, SI +6 more
core +1 more source
Nanodiamond Quantum Sensors for Probing Free Radical Biology
Advanced Functional Materials, EarlyView.Free radicals play key roles in cellular signaling and disease but remain difficult to measure in living systems. Nanodiamonds (NDs) with nitrogen‐vacancy (NV) centers enable quantum sensing of local magnetic noise via T₁ relaxometry, providing nondestructive radical detection in living cells.
Qi Lu, Yingke Wu, Tanja Weil
wiley +1 more source
Labile hypertension in the clinic
Türk Kardiyoloji Derneği Arşivi, 2019 Labile hypertension is a common problem in daily clinical practice. It is defined as a rapid, temporary rise in blood pressure to above 140/90 mm Hg, most often due to emotional stress, followed by a return to normal values.
Nil Özyüncü, Nail Çağlar
doaj +1 more source
Autonomic dysregulation and phenobarbital in patients with masked primary hypertension
Heliyon, 2020 Introduction: Primary hypertension can be masked and be responsible of a severe impact on the target bodies. The purpose of this study was to see if Phenobarbital at low dose is able to decrease the sympathetic hyperactivity assessed by cardiovascular ...
Mustapha EL. Bakkali +3 more
doaj +1 more source
Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factors. [PDF]
, 2014 The age at diagnosis of pulmonary arterial hypertension (PAH) and the prevalence of cardiovascular (CV) risk factors are increasing. We sought to determine whether the response to drug therapy was influenced by CV risk factors in PAH patients. We studied
Charalampopoulos, A +9 more
core +1 more source
Advanced Materials, EarlyView.An overview of design principles and scalable fabrication strategies for multifunctional bio‐based packaging. Radiative cooling films, modified‐atmosphere films/membranes, active antimicrobial/antioxidant platforms, intelligent optical/electrochemical labels, and superhydrophobic surfaces are co‐engineered from material chemistry to mesoscale structure
Lei Zhang +6 more
wiley +1 more source
Magnitude of the Difference Between Clinic and Ambulatory Blood Pressures and Risk of Adverse Outcomes in Patients With Chronic Kidney Disease. [PDF]
, 2019 Background Obtaining 24-hour ambulatory blood pressure ( BP ) is recommended for the detection of masked or white-coat hypertension. Our objective was to determine whether the magnitude of the difference between ambulatory and clinic BP s has prognostic ...
Bae, Se Ri +7 more
core +1 more source